Status:
COMPLETED
Outcomes of Patients With Osteopetrosis Weight-bearing Bone Fractures
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Osteopetrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Osteopetrosis is a rare genetic disorder characterized by the abnormal hardening and density of bones, leading to increased brittleness and susceptibility to fractures. This condition presents signifi...
Detailed Description
Osteopetrosis, also known as marble bone disease, is a rare genetic disorder that leads to the abnormal hardening and densification of bones due to defective osteoclast-mediated bone resorption. This ...
Eligibility Criteria
Inclusion
- All patients with adult osteopetrosis above 18 years of age
Exclusion
- Non-weight-bearing fractures Non-osteopetrosis patients Pediatric patients Previous fracture surgery Concurrent bone conditions Inability to follow up Infection at fracture site Severe comorbidities Pregnancy Non-surgical treatment preference
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 24 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06521580
Start Date
January 1 2022
End Date
June 24 2024
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Ainy-Cairo University- Faculty of Medicine
Cairo, Manial, Egypt, 11956